Finally, something of substance coming out of the company. I have to admit I already assumed this to be the case given results are to come out soon. However this is a quality announcement.
Foxgang, I appreciate your comments and believe me no hard feelings. Do not forget, I own stock in this company and it's been well over two years now. The stock has gone nowhere. So my views are realistic and they are based on the company's performance to date. If I have to wait 2+ years to see something real coming out of this crew then it's not me you should be upset with.
What this company needs is an activist investor - if you are able to do so. What I would suggest, get to know the management team and push them hard. I am pleased to see today's enrollment data as it is a milestone.
It looks like an Ascending Differential Leibniz curve with a post progressive integral sub-factor. Definitely going higher.
This is a good sign but it doesn't mean the stock is going much higher. Be practical for a second, low volume and flat stock price means not a lot of buying and selling - so essentially we are in a quiet period. Investors are waiting for the next binary event, which is the follow up results of the ph IIa trials. And I mention yet again, this is the #1 dumbest stock to short on the market. The risk/reward on the short side is not worth it even to the smallest of short sellers.
Get used to it. You have to dig to find worthwhile text on these boards. I personally pan in and out when I have a few minutes throughout the week. I'd say once or twice per week I find something that is educational or meaningful. The rest of the time I'm in entertainment mode.
Hey, we have to give credit where credit is due. Just by looking at his name I'm sure he doesn't have the juice to be a big short seller. But he correctly predicted BIIB's drop to date. Let's see where this goes from here.
You called this one right on the spot - great guess and congrats!
Even better, BIIB is now back over $300. But on the flip side, it's still way way below where it should and needs to be. Let's hope we now start to see a sustained rise.
You picked a really bad day to show up on this board. Anytime AVXL is quiet on low volume the dregs come out and want to say something. They have nothing better to do & are just looking for attention.
Haven't been here for a week or so, but looking at what is posting today I think we found the bottom of the barrel of posters. The stock is quiet today - just go home and relax.
So bet down on the market and GL. The fact that you are foaming at the mouth to tell everyone the market is going down when in fact you know absolutely 0 is a show of just how dumb you are.
Stop sending garbage about this drug getting approved next month or this year. It's nonsense. Fast track is still two years, not 6 months unless it is an issue of national security. This drug needs to go through real phase II and phase III trials just like everyone else. Ok, perhaps you can merge the two if results are great and speed it up a little to perhaps early 2017 approval.
This stock will continue to rise if ongoing progress is good. Plain and simple. Stop saying it's going to go to $10 next month, $50 next year. Nobody believes this nonsense.
Thank you for regurgitating FDA lingo. Now for the reality. There are no drugs (absolutely none) in this stage that get "fast" approval. Fast track, EAP, whatever - you are dealing with a bureaucratic entity that does not move fast unless there is an act of terror or threat to the US. This drug cannot and will not get approved anytime in the next 18 months - it's impossible so get it out of your head. That said, this is the most exciting AD treatment around today and perhaps ever to date. So enjoy the ride but with a reasonable approach.